Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients
NCT05891795Phase 2Active, not recruiting
- Sponsor
- Stanford University
- Start
- Jul 2024
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of clascoterone in acne vulgaris, sponsored by Stanford University. Started Jul 2024; status: active, not recruiting.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05891795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05891795.